Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
doi: 10.1186/1479-5876-9-81 254 MandaranoAHMayaJGiloteauxLPetersonDLMaynardMGottschalkCGet al
COA-TRN Documentation Batch-specific Certificate of Analysis available for full transparency
No serious side effects or withdrawals were reported
The SURPASS program (for type 2 diabetes) and SURMOUNT program (for obesity) together enrolled over 20,000 participants across multiple Phase III trials
Originally studied for gastric protection, BPC-157 shows multi-organ cytoprotection and inflammation control, which may translate to less edema and improved healing conditions
Use CPT 96372 when: A nurse or provider gives the injection in the office The drug is separately reportable and you list it on the claim The reason for the injection is medically necessary The procedure isnt already bundled into another service or E/M visit Documentation includes dose, route, and site of administration Dont use it when: The injection is part of a surgical package or global period The visit was solely for the injection and no separate service was provided The patient self-administered the drug You didnt provide documentation of the administration 96372 is a standalone code, its not supposed to rely on unrelated services unless certain criteria are met like modifier 25
US$ 20.54
US$ 28.50
US$ 21.82
